Search

Current status of the Clinical Trials Regulation

HemAffairs Article #2 – June 2019

In 2014 the European Parliament approved the Clinical Trials Regulation (CTR) that is supposed to replace the Clinical Trials Directive (CTD) from 2001. Five years later, the regulation has not yet become applicable.

Read more

Ibrutinib improves survival in CLL and SLL patients: Results From the RESONATE Study.

 

Patients with chronic lymphoid leukemia (CLL) or small lymphocytic lymphoma (SLL) who experience short response duration or adverse cytogenetics have poor outcomes.

Read more

EHA Library - watch selected Congress content

On the EHA Library, you can find educational resources and browse open-source material from past EHA Congresses and Meetings. You can already browse the EHA2024 Congress abstracts and select content on the EHA Library.

Read more

Immunoglobulin shortages in the spotlight: EMA, SUPPLY and the SoHO Regulation

EMA executive director Emer Cooke welcoming participants including EHA at the Shortages Workshop, March 1

 

Shortages of immunoglobulins and the need to increase and sustain plasma supplies have moved to the center of the EU policy and regulatory stage.

Read more

Chairs and Members

ChairJosep Maria Ribera, Hospital Germans Trias i Pujol (Spain)

Co-chairAdele Fielding, University College London (United Kingdom)

SWG Steering Committee
Anthony Moorman, Newcastle University (United Kingdom)
Cyril Salek, Charles University in Prague (Czechia)
Helene Hallböök, Uppsala University (Sweden)
Nicola Gökbuget, Frankfurt University Cancer Centre (Germany)
Sabina Chiaretti, Sapienza…

Read more

More than science: the European Affairs program at EHA2023

To develop and administer safe, innovative and effective treatments for patients with blood diseases, hematologists need an effective and enabling regulatory environment.

Read more